simvastatin has been researched along with Esophageal Varices in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, V; Choudhary, A; Jindal, A; Kumar, G; Sarin, SK; Vijayaraghavan, R | 1 |
| Albrecht, J; Aytaman, A; Baffy, G; Bajaj, J; Garcia-Tsao, G; Hernaez, R; Hunt, K; Ioannou, G; Johnson, K; Kanwal, F; Kaplan, DE; Lee, TH; Mehta, R; Monto, A; Pandya, P; Schaubel, D; Taddei, TH | 1 |
| Bosch, J; Iwakiri, Y | 1 |
| Baiges, A; Bosch, J; Hernández-Gea, V | 1 |
| Abraldes, JG; Tandon, P | 1 |
| da Silva, AC; Kunz, DG; Marchiori, RC; Mattos, DE; Pollo-Flores, P; Rezende, GF; Santos, UC; Soldan, M | 1 |
| Abraldes, JG; Albillos, A; Aracil, C; Bosch, J; Calleja, JL; Castellote, J; García-Pagán, JC; Genesca, J; Hernandez-Guerra, M; Rodriguez, M; Torres, F; Turnes, J; Villanueva, C | 1 |
| Chaudhry, T; Dillon, A; Rowe, IA | 1 |
2 review(s) available for simvastatin and Esophageal Varices
| Article | Year |
|---|---|
The portal hypertension syndrome: etiology, classification, relevance, and animal models.
Topics: Adrenergic beta-Antagonists; Animals; Ascites; Carcinoma, Hepatocellular; Early Detection of Cancer; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Healthy Lifestyle; Hemorrhage; Hepatic Encephalopathy; Hepatic Veins; Humans; Hypertension, Portal; Hypolipidemic Agents; Ligation; Liver Cirrhosis; Liver Neoplasms; Models, Animal; Prognosis; Simvastatin | 2018 |
Pharmacologic prevention of variceal bleeding and rebleeding.
Topics: Adrenergic beta-Antagonists; Atorvastatin; Carbazoles; Carvedilol; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Portal; Incidence; Liver; Liver Cirrhosis; Nitric Oxide Synthase Type III; Portal Pressure; Propanolamines; Propranolol; Simvastatin; Splanchnic Circulation | 2018 |
4 trial(s) available for simvastatin and Esophageal Varices
| Article | Year |
|---|---|
Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial.
Topics: Adrenergic beta-Antagonists; Adult; Carvedilol; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemodynamics; Hepatic Veins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Cirrhosis; Male; Middle Aged; Portal Pressure; Primary Prevention; Simvastatin; Treatment Outcome; Venous Pressure | 2020 |
SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation.
Topics: Esophageal and Gastric Varices; Fibrosis; Gastrointestinal Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Cirrhosis; Liver Neoplasms; Prospective Studies; Retrospective Studies; Simvastatin | 2021 |
Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial.
Topics: Aged; Double-Blind Method; Endosonography; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Portal Pressure; Simvastatin; Treatment Outcome; Ultrasonography, Doppler, Color; Venous Pressure | 2015 |
Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.
Topics: Adrenergic beta-Antagonists; Aged; Combined Modality Therapy; Double-Blind Method; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Ligation; Liver Cirrhosis; Male; Middle Aged; Proportional Hazards Models; Recurrence; Rhabdomyolysis; Risk Factors; Simvastatin; Spain; Time Factors; Treatment Outcome | 2016 |
2 other study(ies) available for simvastatin and Esophageal Varices
| Article | Year |
|---|---|
Therapies: Drugs, Scopes and Transjugular Intrahepatic Portosystemic Shunt--When and How?
Topics: Adrenergic beta-Antagonists; Antibiotic Prophylaxis; Anticholesteremic Agents; Balloon Occlusion; Combined Modality Therapy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Ligation; Liver Cirrhosis; Portasystemic Shunt, Transjugular Intrahepatic; Simvastatin; Stents | 2015 |
Uncertain Benefits of Simvastatin in the Treatment of Patients With Variceal Hemorrhage.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Simvastatin; Varicose Veins | 2016 |